PET Radiopharmaceuticals for Imaging Integrin Expression: Tracers in Clinical Studies and Recent Developments
- Standort
-
Deutsche Nationalbibliothek Frankfurt am Main
- Umfang
-
Online-Ressource
- Sprache
-
Englisch
- Erschienen in
-
In: BioMed Research International 2014 (2014).
- Schlagwort
-
-
Krebs
Onkologie
- Ereignis
-
Veröffentlichung
- (wo)
-
Erlangen
- (wer)
-
Friedrich-Alexander-Universität Erlangen-Nürnberg (FAU)
- (wann)
-
2014
- Urheber
- URN
-
urn:nbn:de:bvb:29-opus4-58850
- Rechteinformation
-
Der Zugriff auf das Objekt ist unbeschränkt möglich.
- Letzte Aktualisierung
-
14.08.2025, 10:56 MESZ
Datenpartner
Dieses Objekt wird bereitgestellt von:
Deutsche Nationalbibliothek. Bei Fragen zum Objekt wenden Sie sich bitte an den Datenpartner.
Deutsche Nationalbibliothek. Bei Fragen zum Objekt wenden Sie sich bitte an den Datenpartner.
Beteiligte
- Haubner, Roland
- Maschauer, Simone
- Prante, Olaf
- Friedrich-Alexander-Universität Erlangen-Nürnberg (FAU)
Entstanden
- 2014
Ähnliche Objekte (12)
Molecular imaging : radiopharmaceuticals for PET and SPECT
PET Radiopharmaceuticals for Imaging Chemotherapy-Induced Cardiotoxicity
Hydrophilic and lipophilic radiopharmaceuticals as tracers in pharmaceutical development: In vitro – In vivo studies
Emerging PET Tracers in Cardiac Molecular Imaging
Quantitative comparative analysis of amyloid PET images using three radiopharmaceuticals
Will extended field-of-view PET/CT depopulate the graveyard of failed PET radiopharmaceuticals?
PSMA-targeting radiopharmaceuticals for prostate cancer Therapy: recent developments and future perspectives
PET Tracers for Imaging Cardiac Function in Cardio-oncology
Potential PET tracers for imaging of tumor-associated macrophages
Are we “preparing” radiopharmaceuticals?
Innovative complexation strategies for the introduction of short-lived PET isotopes into radiopharmaceuticals
Innovative Complexation Strategies for the Introduction of Short-lived PET Isotopes into Radiopharmaceuticals
Molecular imaging : radiopharmaceuticals for PET and SPECT
PET Radiopharmaceuticals for Imaging Chemotherapy-Induced Cardiotoxicity
Hydrophilic and lipophilic radiopharmaceuticals as tracers in pharmaceutical development: In vitro – In vivo studies
Emerging PET Tracers in Cardiac Molecular Imaging
Quantitative comparative analysis of amyloid PET images using three radiopharmaceuticals
Will extended field-of-view PET/CT depopulate the graveyard of failed PET radiopharmaceuticals?
PSMA-targeting radiopharmaceuticals for prostate cancer Therapy: recent developments and future perspectives
PET Tracers for Imaging Cardiac Function in Cardio-oncology
Potential PET tracers for imaging of tumor-associated macrophages
Are we “preparing” radiopharmaceuticals?
Innovative complexation strategies for the introduction of short-lived PET isotopes into radiopharmaceuticals
Innovative Complexation Strategies for the Introduction of Short-lived PET Isotopes into Radiopharmaceuticals
Molecular imaging : radiopharmaceuticals for PET and SPECT
PET Radiopharmaceuticals for Imaging Chemotherapy-Induced Cardiotoxicity
Hydrophilic and lipophilic radiopharmaceuticals as tracers in pharmaceutical development: In vitro – In vivo studies
Emerging PET Tracers in Cardiac Molecular Imaging
Quantitative comparative analysis of amyloid PET images using three radiopharmaceuticals
Will extended field-of-view PET/CT depopulate the graveyard of failed PET radiopharmaceuticals?
PSMA-targeting radiopharmaceuticals for prostate cancer Therapy: recent developments and future perspectives
PET Tracers for Imaging Cardiac Function in Cardio-oncology
Potential PET tracers for imaging of tumor-associated macrophages
Are we “preparing” radiopharmaceuticals?
Innovative complexation strategies for the introduction of short-lived PET isotopes into radiopharmaceuticals